Cargando…
Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development
Nowadays, patients with chronic hepatitis C in all countries are generally treated with interferon (IFN), and more than 50% of patients become HCV-RNA negative following PEG-IFN plus ribavirin therapy, but unfortunately, the IFN therapy is not effective in about 70% of patients with HCV-associated L...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scholarly Research Network
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195877/ https://www.ncbi.nlm.nih.gov/pubmed/22084728 http://dx.doi.org/10.5402/2011/390676 |